Abstract
The paper presents an overview of clinical manifestations and histopathologic findings in different organs in microvascular thrombotic and microangiopathic antiphospholipid syndrome (MAPS). Subsets of antiphospholipid syndrome (APS) are presented and defined. Clinico-pathologic correlations seem insufficient so far, because of a lack of detailed systematic studies of the histopathology in different organs. Based on their own autopsy and biopsy studies, the authors propose a novel categorization of histopathologic lesions that occur in patients with classic and catastrophic APS. In addition to the already accepted category of a microvascular thrombotic type of lesions, microangiopathic lesions consistent with thrombotic microangiopathy are proposed to be included in new revised classification criteria for definite APS. Microvascular thrombotic and so far underestimated microangiopathic histopathologic lesions have been shown to appear in various combinations and of different ages in patients with both classic and catastrophic APS, which fits into the concept of MAPS. These preliminary findings of our studies are also in line with the most recent hypothesis of two main mechanisms in the pathogenesis of APS, emphasizing a key role of endothelial cell affection induced by aPL on the one hand and interference with coagulation cascade on the other side.
Similar content being viewed by others
References
Hughes G, Harris EN, Gharavi A (1986) The anticardiolipin syndrome. J Rheumatol 13:486–489
Shoenfeld Y (2003) Systemic antiphospholipid syndrome. Lupus 12:497–849
Asherson RA (1992) The catastrophic antiphospholipid syndrome. J Rheumatol 19:508–512
Lie JT (1997) Prevalence and pathology of vascular occlusive disease in the antiphospholipid syndrome. Cardiovasc Pathol 6:185–195
Asherson RA, Cervera R, Piette JC et al (1998) Catastrophic antiphospholipid syndrome. Clinical and laboratory features in 50 patients. Medicine 80:195–207
Wilson WA, Gharavi AE, Koike T et al (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis Rheum 42:1309–1311
Levine JS, Branch DW, Rauch J (2002) The antiphospholipid syndrome. NEJM 346:752–763
Baker WF, Bick RL (2008) The clinical spectrum of antiphospholipid syndrome. Hematol Oncol Clin North Am 22:33–52
Montero PJ, Franco V, Strauss Y, La Pena A (2008) The antiphospholipid syndrome. Medicrit 5:27–40
Vora SK, Asherson RA, Erkan D (2006) Catastrophic antiphospholipid syndrome. J Intens Care Med 21:144–159
Miyakis S, Lochshin MD, Atsumi T et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295–306
Asherson RA (2006) New subsets of the antiphospholipid syndrome in 2006: “PRE-APS” (probable APS) and microangiopathic antiphospholipid syndrome (“MAPS”). Autoimmun Rev 6:76–80
Asherson RA, Cervera R (2008) Microvascular and microangiopathic antiphospholipid associated syndromes (“MAPS”): Semantic or antisemantic. Autoimmun Rev 7:164–167
Espinosa G, Buciarelli S, Cervera R (2004) Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies. Ann Rheum Dis 63:730–736
Reyes E, Alarcon-Segovia D (2002) Pathology of the antiphospholipid syndrome. In: Asherson RA et al (ed) The Antiphospholipid Syndrome II: Autoimmune Thrombosis. Elsevier, Amsterdam, pp 131–136
Cervera R, Piette JC, Font J et al (2002) Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 46:1019–1027
Nahass GT (1997) Antiphospholipid antibodies and the antiphospholipid antibodies syndrome. J Am Acad Dematol 36:149–168
Alegre VA, Winkelmann RK (1988) Histopathologic and immunofluorescence study of skin lesions associated with circulating anticoagulant. J Am Acad Dermatol 19:117–124
Smith KJ, Skelton HG, James WD et al (1990) Cutaneous histopathologic findings in “antiphospholipid syndrome”. Arch Dermatol 126:1176–1183
Stephansson EA, Niemi KM, Jouhikainen T et al (1991) Lupus anticoagulant and the skin. A long term follow-up of SLE patients with special reference to histopathologic findings. Acta Derm Venereol 71:416–422
Grob JJ, Bonerandi JJ (1986) Cutaneous manifestations associated with the presence of the lupus anticoagulant: a report of two cases and the review of the literature. J Am Acad Dermatol 15:211–219
Selva A, Ordi J, Roca M et al (1994) Pyoderma gangrenosum-like ulcers associated with lupus anticoagulant. Dermatology 189:182–184
Hughson MD, McCarty GA, Brumback RA (1995) Spectrum of vascular pathology affecting patients with the antiphospholipid syndrome. Hum Pathol 26:716–724
Lie JT (1994) Vasculitis in the antiphospholipid syndrome: culpit or consort. J Rheumatol 21:397–399
Mujic F, Lloyd M, Cuadrado MJ et al (1995) Prevalence and clinical significance of subungual splinter hemorrhages in patients with the antiphospholipid syndrome. Clin Exp Rheumatol 13:327–331
Ornstein MH, Rand JH (1994) An association between refractory HELLP syndrome and antiphospholipid antibodies during pregnancy; a report of 2 cases. J Rheumatol 21:1360–1364
Frances C, Piette CP (2002) Dermatologic manifestations in the antiphospholipid syndrome. In: Asherson RA et al (ed) The Antiphospholipid Syndrome II: Autoimmune Thrombosis. Elsevier, Amsterdam, pp 235–244
Frances C, Piette JC, Asherson RA (2006) Dermatologic aspects of antiphospholipid antibody syndrome. In: Sarzi-Puttini P et al (eds) Handbook of Systemic Autoimmune Diseases. Elsevier 5:103–117
Frances C, Niang S, Laffitte E et al (2005) Dermatologic manifestations of the antiphospholipid syndrome: two hundred consecutive cases. Arthritis Rheum 52:1785–1793
Šipek-Dolničar A, Hojnik M, Božič B et al (2002) Clinical presentations and vascular histopathology in autopsied patients with systemic lupus erythematosus and anticardiolipin antibodies. Clin Exp Rheumatol 20:335–342
Creamer D, Black MM, Calonje E (2000) Reactive angioendotheliomatosis in association with the antiphospholipid syndrome. J Am Acad Dermatol 42:903–906
Thai KE, Barrett W, Kossard S (2003) Reactive angioendotheliomathosis in the setting of antiphospholipid syndrome. Australas J Dermatol 14:99–106
Sharkey MP, Daryanani II, Gillett MB, Jones SK (2002) Localized cutaneous necrosis associated with the antiphospholipid syndrome. Australas J Dermatol 43:218–220
Tomb R, Maalouf E, Attoui S (2008) Cutaneous nodular lesions and antiphospholipid syndrome. Ann Dermatol Venereol 135:484–487
Bucciarelli S, Cervera R, Espinosa G et al (2006) Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors. Autoimmun Rev 6:72–75
Maggiorini M, Knoblauch A, Schneider J, Russi EW (1997) Diffuse microvascular pulmonary thrombosis associated with primary antiphospholipid antibody syndrome. Eur Respir J 10:727–730
Kerr JE, Poe J, Kramer Z (1997) Antiphospholipid antibody syndrome presenting as a refractory noninflammatory pulmonary vasculopathy. Chest 112:1707–1710
Deane KD, West SG (2005) Antiphospholipid antibodies as a cause of pulmonary capillaritis and diffuse alveolar hemorrhage: a case series and literature review. Semin Arthritis Rheum 35:154–165
Espinosa G, Cervera R, Garcia-Carrasco et al (2002) Pulmonary involvement in the antiphospholipid syndrome. In: Wells AU, Denton CP (eds) Handbook of Systemic Autoimmune Disease. Amsterdam, Elsevier 2:137–145
Šipek-Dolničar A, Hojnik M, Rozman B et al (2000) Small vessel thrombosis without major thrombotic events in systemic lupus erythematosus patients with antiphospholipid syndrome. Wien Klin Wochenschr 112:707–710
Long BR, Leya F (2008) The role of antiphospholipid syndrome in cardiovascular disease. Hematol Oncol Clin North Am 22:79–94
Leung WH, Wong KL, Lau et al (1990) Association between antiphospholipid antibodies and cardiac abnormalities in patients with systemic lupus erythematosus. Am J Med 89:411–419
Murphy J, Leach IH (1989) Findings at necropsy in the heart of a patient with anticardiolipin syndrome. Br Heart J 62:61–64
Brown JH, Doherty CC, Allen DC et al (1988) Fatal cardiac failure due to myocardial microthrombi in systemic lupus erythematosus. Br Med J (Clin Res Ed) 296:1505
Kaplan SD, Chartash EK, Pizzarello RA et al (1992) Cardiac manifestations of the antiphospholipid syndrome. Am Heart J 124:1331–1338
Von Landenberg P, Asherson RA, Piette JC (2002) Renal, hepatic and other intraabdominal manifestations in the antiphospholipid syndrome. In: Asherson et al (ed) The Antiphospholipid Syndrome II: Autoimmune Thrombosis. Elsevier, Amsterdam, pp 189–204
Uthman I, Khamashta M (2007) The abdominal manifestation of the antiphospholipid syndrome. Rhematol 46:1641–1647
Nakamura H, Uchara H, Okada T (1989) Occlusion of small hepatic veins associated with systemic lupus erythematosus with the lupus anticoagulant and anti-cardiolipin antibody. Hepatogastroenterol 36:393–397
Barak N, Orion Y, Schneider M et al (1999) Case report: hepatic involvement in antiphospholipid syndrome. J Gastroenterol Hepatol 14:1124–1128
Kalman DR, Khan A, Romain PL, Nompleggi DJ (1996) Giant gastric ulceration associated with antiphospholipid antibody syndrome. Am J Gastroenterol 91:1244–1247
Briley DP, Coull BM, Goodnight SH (1989) Neurological disease associated with antiphospholipid syndrome. Ann Neurol 25:221–227
Asherson RA, Cervera R (2003) The antiphospholipid syndrome: multiple faces beyond the classical presentation. Autoimmun Rev 2:140–151
Cuadrado MJ, Khamashta MA, Ballesteros A et al (2000) Can neurologic manifestations of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature. Medicine 79:57–68
Tektonidou MG, Grigorios Kotoulas NV, Antoniou A, Moutsopoulos HM (2006) Cognitive deficits in patients with antiphospholipid syndrome: association with clinical, laboratory, and brain magnetic resonance imaging findings. Arch Intern Med 166:2278–2284
Brey RL, Levine SR, Stallworth CL (2002) Neurologic manifestations in the antiphospholipid syndrome. In: Asherson RA et al (ed) The Antiphospholipid Syndrome II: Autoimmune Thrombosis. Elsevier, Amsterdam, pp 155–168
Shoenfeld Y, Nahum A, Korczyn AD et al (2003) Neuronal-binding antibodies from patients with antiphospholipid syndrome induce cognitive deficits following intrathecal passive transfer. Lupus 12:436–442
Hugson MD, McCarty GA, Sholer CM, Brumback RA (1993) Thrombotic cerebral arteriopathy in patients with the antiphospholipid syndrome. Mod Pathol 6:644–653
Miesbach W, Gilzinger A, Gokpinar B et al (2006) Prevalence of antiphospholipid antibodies in patients with neurological symptoms. Clin Neurol Neurosur 108:135–142
Durrani OM, Gordon C, Murray PI (2002) Primary anti-phospholipid antibody syndrome (APS). Surv Ophthalmol 4:215–238
Asherson RA, Merry P, Acheson JF et al (1989) Antiphospholipid antibodies: a risk factor for occlusive ocular vascular disease in systemic lupus erythematosus and the primary antiphospholipid syndrome. Ann Rheum Dis 48:358–361
Castanon C, Amigo MC, Banales JL et al (1995) Ocular vaso-occlusive disease in primary antiphospholipid syndrome. Ophthalmology 102:256–262
Giorgi D, Pace F, Giorgi A et al (1999) Retinopathy in systemic lupus erythematosus: pathogenesis and approach to therapy. Hum Immunol 60:688–696
Falcini F, Taccetti G, Ermini M et al (1997) Catastrophic antiphospholipid antibody syndrome in pediatric systemic lupus erythematosus. J Rheumatol 24:389–392
Asherson RA, Cervera R, Piette JC et al (2001) Catastrophic antiphospholipid syndrome. Clues to the pathogenesis from a series of 80 patients. Medicine 80:355–377
Tsirpanlis G, Moustakas G, Sakka E et al (2005) Catastrophic antiphospholipid syndrome in a 14-year-old child. Pediatr Nephrol 20:519–521
Avčin T, Cimaz R, Silverman ED et al (2008) Pediatric antiphospholipid syndrome: clinical and immunologic features of 121 patients in an international registry. Pediatrics 122:1100–1107
Orsino A, Schneider R, DeVeber G et al (2004) Childhood acute myelomonocytic leukemia (AML-M4) presenting as catastrophic antiphospholipid antibody syndrome. J Pediatr Hematol Oncol 26:327–330
Sharma J, Karthik S, Rao S et al (2005) Catastrophic antiphospholipid antibody syndrome. Pediatr Nephrol 20:998–999
Park JM, Shin JI, Shin YH et al (2007) Catastrophic antiphospholipid syndrome in a 7-year-old girl. Clin Rheumatol 26:1011–1013
Iman S, Sidki K, al-Marshedy AR, Judzewitsch R (1991) Addison’s disease, hypertension, renal and hepatic microthrombosis in ‘primary’ antiphospholipid syndrome. Postgrad Med J 67:385–388
De-Leon-Bojorge B, Zaltzman-Girsevich S, Ortega-Salgado A et al (2006) Thrombotic microangiopathy involving the gallbladder as an unusual manifestation of systemic lupus erythematosus and antiphospholipid syndrome: case report and review of the literature. World J Gastroenterol 12:7206–7209
Do Sameiro Faria M, Mota C, Barlot J et al (2000) Hemolytic uremic syndrome cardiomyopathy, cutaneous vasculopathy and antiphospholipid activity. Nephrol Dial Transplant 15:1891–1892
Meglič A, Grosek Š, Benedik-Dolničar M, Avčin T (2008) Atypical haemolytic uremic syndrome complicated by microangiopathic antiphospholipid-associated syndrome. Lupus 17:842–845
Symmers WSC (1952) Thrombotic microangiopathic haemolitic anemia (thrombotic microangiopathy). Br Med J 2:897–903
Thoenes W, John HD (1980) Endotheliotropic (hemolytic) nephroangiopathy and its various manifestation forms (thrombotic microangiopathy, primary malignant nephrosclerosis, hemolytic–uremic syndrome). Klin Wochenschr 58:173–184
Asherson RA, Cervera R, Merrill JT (2006) Thrombotic microangiopathic antiphospholipid syndromes: a continuum of conditions. Future Rheumatol 1:355–364
Asherson RA, Pierangeli S, Cervera R (2007) Is there a microangiopathic antiphospholipid syndrome. Ann Rheum Dis 66:429–432
Vega-Ostertag ME, Pierangeli SS (2007) Mechanisms of aPL-mediated thrombosis: effects of aPL on endothelium and platelets. Curr Rheumatol Rep 9:190–197
O’Neil KM (2007) Role of complement in antiphospholipid syndrome. Curr Rheumatol Rep 9:205–211
Mackworth-Young CG (2004) Antiphospholipid syndrome: multiple mechanisms. Clin Exp Immunol 136:393–401
D’Agati V, Kunis C, Williams G, Appel GB (1990) Anti-cardiolipin antibody and renal disease: a report of three cases. J Am Soc Nephrol 1:777–784
Nochy D, Daugas E, Droz D et al (1999) The intrarenal vascular lesions associated with primary antiphospholipid syndrome. J Am Soc Nephrol 10:507–518
Amigo MC, Garcia-Torres R (2000) Kidney disease in antiphospholipid syndrome. In: Khamashta MA (ed) Hughes Syndrome. Antiphopholipid Syndrome. Springer, Berlin, pp 71–81
Seshan SV (2000) Vascular complications in lupus nephritis and lupus-like syndromes. Wien Klin Wochenschr 112:687–691
Daugas E, Nochy D, Le Thi Huong D et al (2002) Antiphospholipid syndrome nephropathy in systemic lupus erythematosus. J Am Soc Nephrol 13:42–52
Amigo MC (2006) Kidney disease in antiphospholipid syndrome. Rheum Dis Clin North Am 32:509–522
Hill GS, Nochy D (2007) Antiphospholipid syndrome in systemic lupus erythematosus. J Am Soc Nephrol 18:2461–2464
Jara LJ, Medina G, Vera-Lastra O (2007) Systemic antiphospholipid syndrome and atherosclerosis. Clin Rev Allerg Immunol 32:172–177
Moroni G, Ventura D, Riva P et al (2004) Antiphospholipid antibodies are associated with an increased risk for chronic renal insufficiency in patients with lupus nephritis. Am J Kidney Dis 43:28–36
Fakhouri F, Noël LH, Zuber J et al (2003) The expanding spectrum of renal diseases associated with antiphospholipid syndrome. Am J Kidney Dis 41:1205–1211
Asherson RA, Espinosa G, Cervera R et al (2005) Disseminated intravascular coagulation in catastrophic antiphospholipid syndrome: clinical and haematological characteristics of 23 patients. Ann Rheum Dis 64:943–946
Voung PN, Berry SC (2002) The Pathology of Vessels. Springer, Berlin, pp 35–67
Bontas E, Tanikawa A, Bartos D et al (2006) Polymorphism of skin involvement in Hughes (antiphospholipid) syndrome. J Thromb Haemost 4:295–306
Rollino C, Mazzucco G, Boero R (2003) Is it possible to diagnose primary anti-phospholipid syndrome (PAPS) on the basis of renal thrombotic microangiopathy (PAPS nephropathy) in the absence of other thrombotic process. Renal Failure 25:1043–1049
Saracino A, Ramuni A, Pannarale G, Coratelli P (2005) Kidney disease associated with primary antiphospholipid syndrome: clinical signs and histopathologic features in an case experience of five cases. Clin Nephrol 63:471–476
Griffiths MH, Papadaki L, Neild GH (2000) The renal pathology of primary antiphospholipid syndrome: a distinctive form of endothelial injury. Q J Med 93:457–467
Tektonidou MG, Sotsiou F, Nakopoulou L et al (2004) Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies. Arthritis Rheum 50:2569–2579
Asherson RA, Cervera R, Shepshelovich D, Shoenfeld Y (2006) Nonthrombotic manifestations of the antiphospholipid syndrome: away from thrombosis. J Rheumatol 33:1038–1344
Pilling J, Cutaia M (1997) The antiphospholipid antibody syndrome: a vascular disease with pulmonary manifestations. Chest 112:1451–1453
Johnson CM, Mureebe L, Silver D (2005) Hypercoagulable states: a review. Vasc Endovasc Surg 39:123–133
Moake JL (2002) Thrombotic microangiopathies. N Engl J Med 347:589–600
Matsuura E, Kobayashi K, Lopez LR (2008) Preventing autoimmune and infection triggered atherosclerosis for an enduring healthful lifestyle. Autoimmun Rev 7:214–222
Yang YH, Chuang YH, Wang LC et al (2008) The immunobiology of Henoch–Schonlein purpura. Autoimmun Rev 7:179–184
Kallenberg CG (2008) Pathogenesis of PR3-ANCA associated vasculitis. J Autoimmun 30:29–36
Belizna CC, Richard V, Thuillez C et al (2007) Insights into atherosclerosis therapy in antiphospholipid syndrome. Autoimmun Rev 7:46–51
Rav-Acha M, Plot L, Peled N, Amital H (2007) Coronary involvement in Takayasu’s arteritis. Autoimmun Rev 6:566–71
Alard JE, Dueymes M, Youinou P, Jamin C (2007) Modulation of endothelial cell damages by anti-Hsp60 autoantibodies in systemic autoimmune diseases. Autoimmun Rev 6:438–43
Hahn BH, Grossman J, Chen W, McMahon M (2007) The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia. J Autoimmun 28:69–75
Ilaria C, Nebuloni M, Cetin I et al (2007) J Autoimmun 28:160–164
Koike T, Bohgaki M, Amengual O, Atsumi T (2007) Antiphospholipid antibodies: lessons from the bench. J Autoimmun 28:129–33
Acknowledgments
We are grateful to Mrs. Tatjana Kobenter, BSc, Metka Janc, Andreja Drofenik, Nataša Štok-Pfajfer, and Branka Grmek, as well as Mr. Žiga Kušar, BSc for their technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Praprotnik, S., Ferluga, D., Vizjak, A. et al. Microthrombotic/Microangiopathic Manifestations of the Antiphospholipid Syndrome. Clinic Rev Allerg Immunol 36, 109–125 (2009). https://doi.org/10.1007/s12016-008-8104-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12016-008-8104-z